New York Life Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
BIT
New York Life Trust's VRTX Position: Q2 2015 in Review
New York Life Trust sold out of Vertex Pharmaceuticals (VRTX) in Q2 2015, closing a stake of 468 shares — an estimated $55K sold.
New York Life Trust first reported a position in VRTX in Q4 2014 and held it in 2 quarters. The position peaked at $55K in Q1 2015. 500 funds tracked by Wall St. Rank hold VRTX as of Q2 2015.
- New York Life Trust reported no remaining Vertex Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
- New York Life Trust sold 468 Vertex Pharmaceuticals shares in Q2 2015, an estimated $55K.
- New York Life Trust first reported a position in Vertex Pharmaceuticals in Q4 2014 and held it in 2 quarters.
- New York Life Trust's Vertex Pharmaceuticals position peaked at $55K in Q1 2015.
- 500 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2015.
Based on New York Life Trust's 13F filing for Q2 2015, filed 13 Aug 2015.